• Je něco špatně v tomto záznamu ?

Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors

S. Hubackova, E. Davidova, S. Boukalova, J. Kovarova, M. Bajzikova, A. Coelho, MG. Terp, HJ. Ditzel, J. Rohlena, J. Neuzil

. 2020 ; 11 (2) : 110. [pub] 20200207

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012865

Grantová podpora
NV17-30138A MZ0 CEP - Centrální evidence projektů

p53-mutated tumors often exhibit increased resistance to standard chemotherapy and enhanced metastatic potential. Here we demonstrate that inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme of the de novo pyrimidine synthesis pathway, effectively decreases proliferation of cancer cells via induction of replication and ribosomal stress in a p53- and checkpoint kinase 1 (Chk1)-dependent manner. Mechanistically, a block in replication and ribosomal biogenesis result in p53 activation paralleled by accumulation of replication forks that activate the ataxia telangiectasia and Rad3-related kinase/Chk1 pathway, both of which lead to cell cycle arrest. Since in the absence of functional p53 the cell cycle arrest fully depends on Chk1, combined DHODH/Chk1 inhibition in p53-dysfunctional cancer cells induces aberrant cell cycle re-entry and erroneous mitosis, resulting in massive cell death. Combined DHODH/Chk1 inhibition effectively suppresses p53-mutated tumors and their metastasis, and therefore presents a promising therapeutic strategy for p53-mutated cancers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012865
003      
CZ-PrNML
005      
20210507101846.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41419-020-2224-7 $2 doi
035    __
$a (PubMed)32034120
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Hubackova, Sona $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic. sona.hubackova@ibt.cas.cz
245    10
$a Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors / $c S. Hubackova, E. Davidova, S. Boukalova, J. Kovarova, M. Bajzikova, A. Coelho, MG. Terp, HJ. Ditzel, J. Rohlena, J. Neuzil
520    9_
$a p53-mutated tumors often exhibit increased resistance to standard chemotherapy and enhanced metastatic potential. Here we demonstrate that inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme of the de novo pyrimidine synthesis pathway, effectively decreases proliferation of cancer cells via induction of replication and ribosomal stress in a p53- and checkpoint kinase 1 (Chk1)-dependent manner. Mechanistically, a block in replication and ribosomal biogenesis result in p53 activation paralleled by accumulation of replication forks that activate the ataxia telangiectasia and Rad3-related kinase/Chk1 pathway, both of which lead to cell cycle arrest. Since in the absence of functional p53 the cell cycle arrest fully depends on Chk1, combined DHODH/Chk1 inhibition in p53-dysfunctional cancer cells induces aberrant cell cycle re-entry and erroneous mitosis, resulting in massive cell death. Combined DHODH/Chk1 inhibition effectively suppresses p53-mutated tumors and their metastasis, and therefore presents a promising therapeutic strategy for p53-mutated cancers.
650    _2
$a zvířata $7 D000818
650    _2
$a protokoly protinádorové kombinované chemoterapie $x farmakologie $7 D000971
650    _2
$a nádory prsu $x farmakoterapie $x genetika $x metabolismus $x patologie $7 D001943
650    12
$a kontrolní body buněčného cyklu $x účinky léků $7 D059447
650    12
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a checkpoint kinasa 1 $x antagonisté a inhibitory $x genetika $x metabolismus $7 D000071877
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a geny erbB-2 $7 D018734
650    _2
$a HCT116 buňky $7 D045325
650    _2
$a lidé $7 D006801
650    _2
$a leflunomid $x farmakologie $7 D000077339
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a myši transgenní $7 D008822
650    _2
$a oxidoreduktasy působící na CH-CH vazby $x antagonisté a inhibitory $x genetika $x metabolismus $7 D044925
650    _2
$a fenylmočovinové sloučeniny $x farmakologie $7 D010671
650    _2
$a inhibitory proteinkinas $x farmakologie $7 D047428
650    _2
$a pyraziny $x farmakologie $7 D011719
650    _2
$a pyrimidiny $x biosyntéza $7 D011743
650    _2
$a ribozomy $x genetika $x metabolismus $7 D012270
650    _2
$a signální transdukce $7 D015398
650    _2
$a nádorový supresorový protein p53 $x nedostatek $x genetika $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Davidova, Eliska $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Boukalova, Stepana $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic
700    1_
$a Kovarova, Jaromira $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic
700    1_
$a Bajzikova, Martina $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic
700    1_
$a Coelho, Ana $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic
700    1_
$a Terp, Mikkel G $u Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark
700    1_
$a Ditzel, Henrik J $u Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, 5000, Odense, Denmark $u Academy of Geriatric Cancer Research (AgeCare), Department of Oncology, Odense University Hospital, 5000, Odense, Denmark
700    1_
$a Rohlena, Jakub $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic
700    1_
$a Neuzil, Jiri $u Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, 252 50, Czech Republic. j.neuzil@griffith.edu.au $u School of Medical Science, Griffith University, Southport, QLD, 4222, Australia. j.neuzil@griffith.edu.au
773    0_
$w MED00173233 $t Cell death & disease $x 2041-4889 $g Roč. 11, č. 2 (2020), s. 110
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32034120 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101846 $b ABA008
999    __
$a ok $b bmc $g 1651108 $s 1133244
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 11 $c 2 $d 110 $e 20200207 $i 2041-4889 $m Cell death & disease $n Cell Death Dis $x MED00173233
GRA    __
$a NV17-30138A $p MZ0
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace